Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

FDA Approves Combination Treatment for Metastatic Prostate Cancer

The Food and Drug Administration (FDA) approved a new formulation of Yonsa (abiraterone acetate) in combination with methylprednisolone as a... Read More

Prostate Cancer Advocacy Groups See Knowledge Gaps Concerning Disease Stages and Related Treatment Options

The complexity of treating and managing prostate cancer during every stage of the disease, and the involvement of the number... Read More

Xtandi Granted Priority Review for Prostate Cancer Treatment

The Food and Drug Administration granted Xtandi (enzalutamide) a priority review to a supplemental new drug application for the treatment... Read More

Testing for Inherited Gene Mutations in Prostate Cancer Equally Important

More than 12 percent of men with prostate cancer tested positive for hereditary mutations of cancer-causing genes, according to study... Read More

FDA Approves Zytiga for High-Risk Prostate Cancer

Janssen Biotech announced that the Food and Drug Administration has approved Zytiga (abiraterone acetate) in combination with prednisone for high-risk... Read More

Whole Milk Consumption Increases Risk For Prostate Cancer Progression

Men who consume whole milk following their prostate cancer diagnosis may increase their risk for disease recurrence, especially overweight or... Read More

FDA Approves Jevtana for Prostate Cancer Subset

Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant... Read More

Expert Weighs In: Active Surveillance in Prostate Cancer

When it comes to active surveillance and prostate-specific antigen (PSA) screening for localized prostate cancer, the paradigm has been shifting... Read More

Learning to Speak Up With Cancer

What stands in the way of patient-physician communications and how can we get around these barriers? Read more. 

Recent Patterns Indicate PSA Testing Halt in Decline

Previously reported declines in prostate-specific antigen testing have not continued in recent years, and that approximately one-third of men age... Read More

1 2